Topic: New data, new treatment recommendations in metastatic hormone-sensitive PCa
Earn accreditation points
Finish 5 cases, answer 10 questions and Earn 1 credit.
This topic consists of 5 cases
Disease Area: Prostate cancer
Background: New evidence on treatment options for patients with mHSPC is paving the way for a more personalised treatment approach.
Educational Objective: Learn how new clinical data influences the treatment choice in patients with mHPSC: which patients benefit from systemic combination treatment; which patients can benefit from radiotherapy?
Specialty: Urology, medical oncology
Target Audience: CME (intermediate-advanced), Residents (senior)
Latest update: April 2019